188 related articles for article (PubMed ID: 29865086)
1. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of apathy in myotonic dystrophy type 1.
Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
[TBL] [Abstract][Full Text] [Related]
3. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
Raymond K; Levasseur M; Mathieu J; Gagnon C
Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
[TBL] [Abstract][Full Text] [Related]
4. Participation in the chronic phase of stroke.
van der Zee CH; Visser-Meily JM; Lindeman E; Jaap Kappelle L; Post MW
Top Stroke Rehabil; 2013; 20(1):52-61. PubMed ID: 23340071
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
6. Predictors of disrupted social participation in myotonic dystrophy type 1.
Gagnon C; Mathieu J; Jean S; Laberge L; Perron M; Veillette S; Richer L; Noreau L
Arch Phys Med Rehabil; 2008 Jul; 89(7):1246-55. PubMed ID: 18586127
[TBL] [Abstract][Full Text] [Related]
7. Functioning and disability in adults with myotonic dystrophy type 1.
Kierkegaard M; Harms-Ringdahl K; Holmqvist LW; Tollbäck A
Disabil Rehabil; 2011; 33(19-20):1826-36. PubMed ID: 21254917
[TBL] [Abstract][Full Text] [Related]
8. Accomplishment of instrumental activities of daily living and its relationship with cognitive functions in adults with myotonic dystrophy type 1 childhood phenotype: an exploratory study.
Tremblay M; Muslemani S; Côté I; Gagnon C; Fortin J; Gallais B
BMC Psychol; 2021 Apr; 9(1):56. PubMed ID: 33865455
[TBL] [Abstract][Full Text] [Related]
9. Apathy and hypersomnia are common features of myotonic dystrophy.
Rubinsztein JS; Rubinsztein DC; Goodburn S; Holland AJ
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):510-5. PubMed ID: 9576545
[TBL] [Abstract][Full Text] [Related]
10. Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
Gallais B; Gagnon C; Côté I; Forgues G; Laberge L
J Neuromuscul Dis; 2018; 5(1):39-46. PubMed ID: 29278897
[TBL] [Abstract][Full Text] [Related]
11. Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.
LaDonna KA; Venance SL
J Neurosci Nurs; 2015 Oct; 47(5):285-95. PubMed ID: 26348433
[TBL] [Abstract][Full Text] [Related]
12. Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1.
Peric S; Stojanovic VR; Basta I; Peric M; Milicev M; Pavlovic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Mar; 115(3):270-5. PubMed ID: 22695270
[TBL] [Abstract][Full Text] [Related]
13. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients.
Laberge L; Mathieu J; Auclair J; Gagnon É; Noreau L; Gagnon C
Eur Neurol; 2013; 70(5-6):308-15. PubMed ID: 24158106
[TBL] [Abstract][Full Text] [Related]
14. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
15. Restrictions and satisfaction with participation in patients who are ADL-independent after an aneurysmal subarachnoid hemorrhage.
Huenges Wajer IM; Visser-Meily JM; Greebe P; Post MW; Rinkel GJ; van Zandvoort MJ
Top Stroke Rehabil; 2017 Mar; 24(2):134-141. PubMed ID: 27322797
[TBL] [Abstract][Full Text] [Related]
16. Participation Restrictions and Satisfaction With Participation in Partners of Patients With Stroke.
Cox V; Schepers V; Ketelaar M; van Heugten C; Visser-Meily A
Arch Phys Med Rehabil; 2020 Mar; 101(3):464-471. PubMed ID: 31669298
[TBL] [Abstract][Full Text] [Related]
17. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
[TBL] [Abstract][Full Text] [Related]
18. Multiple Case Study of Changes in Participation of Adults with Myotonic Dystrophy Type 1: Importance of Redesigning Accomplishment and Resilience.
Raymond K; Gagnon C; Levasseur M
J Neuromuscul Dis; 2022; 9(6):731-755. PubMed ID: 36214003
[TBL] [Abstract][Full Text] [Related]
19. Participation restriction in childhood phenotype of myotonic dystrophy type 1: a systematic retrospective chart review.
Gagnon C; Kierkegaard M; Blackburn C; Chrestian N; Lavoie M; Bouchard MF; Mathieu J
Dev Med Child Neurol; 2017 Mar; 59(3):291-296. PubMed ID: 27671786
[TBL] [Abstract][Full Text] [Related]
20. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
Gagnon C; Mathieu J; Noreau L
Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
